Nitisinone is a synthetic reversible inhibitor of 4-hydroxyphenylpyruvate dioxygenase used in the treatment of hereditary tyrosinemia type 1 and alkaptonuria. To support the rigorous analytical demands… Read more





Nitisinone is a synthetic reversible inhibitor of 4-hydroxyphenylpyruvate dioxygenase used in the treatment of hereditary tyrosinemia type 1 and alkaptonuria. To support the rigorous analytical demands of pharmaceutical development, this category provides high-quality nitisinone reference standards, including the active pharmaceutical ingredient, related organic impurities, and stable isotope-labelled compounds. Laboratories utilize these materials for critical applications such as impurity profiling, the validation of analytical methods, and routine quality control testing. By incorporating these chemically verified reference materials, researchers can ensure accurate identification and quantification of the drug substance and its associated degradants within complex matrices. Accessing precise, characterized standards is essential for maintaining compliance with regulatory benchmarks throughout the manufacturing and stability testing lifecycles of this therapeutic agent.